Limor Zur-Stoller
Keine laufenden Positionen mehr
Karriereverlauf von Limor Zur-Stoller
Ehemalige bekannte Positionen von Limor Zur-Stoller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROSETTA GENOMICS LTD. | Finanzdirektor/CFO | 06.11.2009 | 01.10.2010 |
| G.F.C GREEN FIELDS CAPITAL LTD. | Finanzdirektor/CFO | 19.04.2011 | - |
| Public Communications Contact | 19.04.2011 | - | |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Direktor/Vorstandsmitglied | 26.04.2011 | - |
| Finanzdirektor/CFO | 19.03.2008 | - | |
| Treasurer | 19.03.2008 | - | |
| RADVIEW SOFTWARE LTD. | Finanzdirektor/CFO | - | - |
| Public Communications Contact | 29.06.2009 | - |
Ausbildung von Limor Zur-Stoller
| Tel-Aviv University | Undergraduate Degree |
Statistik
International
| Israel | 6 |
Operativ
| Director of Finance/CFO | 4 |
| Public Communications Contact | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Technology Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RADVIEW SOFTWARE LTD. | Technology Services |
| ROSETTA GENOMICS LTD. | Health Technology |
| G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
| Private Unternehmen | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Börse
- Insiders
- Limor Zur-Stoller
- Erfahrung
